What is NCIs participation in the NIH Roadmap?
The National Cancer Institute (NCI) is playing a role in a number of activities in the NIH Roadmap for Medical Research. NCI is contributing its expertise to the theme areas and initiatives that align most closely with the Institute’s strategic priorities and overall mission. The NCI is recognized for its leadership in the areas of imaging and for its extensive data on agents that have been developed or considered for development as drugs. This NCI expertise is being applied to advancing the Roadmap Initiative to develop a Comprehensive Trans NIH Imaging Probe Database, an effort that is closely integrated with the PubChem database initiative. The NCI is providing data for over 250,000 compounds that will be available through this public database. NCI is actively participating in two initiatives intended to strengthen translational resources within the Re-engineering the Clinical Research Enterprise component of the NIH Roadmap. The NIH Roadmap Translational Research Core Services init
